Press Releases
2024
-
Indoco Remedies receives tentative ANDA approval from USFDA for Canagliflozin and Metformin Hydrochloride Tablets
June 6, 2024 Indoco Remedies receives final ANDA approval from USFDA for Pregabalin capsules
May 21, 2024-
Receipt of Establishment Inspection Report by Indoco Remedies Limited - Closure of USFDA Inspection of Goa Plant-I
January 18, 2024
2023
-
Indoco Remedies receives tentative ANDA approval from USFDA for Canagliflozin Tablets
December 06, 2023 -
Indoco’s Baddi facility (Unit I) receives GMP certification from EU Health Authority
July 26, 2023 -
Indoco’s Goa facility (Plant III) receives EU GMP certification from the German Health Authority
July 11, 2023 -
Indoco’s Baddi facility receives EUGMP certification from Health Authority of Germany
June 09, 2023 -
Indoco acquires 85 % equity stake in US based FPP Holding Company, LLC.
June 06, 2023 -
Indoco receives EIR for its manufacturing facility in Goa (Plant I)
May 03, 2023
2022
-
Indoco’s AnaCipher CRO clears USFDA inspection with Zero 483s
May 03, 2023 -
Indoco’s AnaCipher CRO clears USFDA inspection with Zero 483s
September 19, 2022 -
Indoco's initiative to promote green energy
August 17, 2022 -
Indoco Remedies receives USFDA approval for Lacosamide Injection USP
April 08, 2022 -
Indoco Remedies receives USFDA approval for Lacosamide Tablets
March 22, 2022
2021
-
Indoco's Clinical Research Organisation – AnaCipher receives accreditation from UKMHRA
August 27, 2021 -
Indoco Remedies donates ECG Machines to PHC centres across Goa
August 06, 2021 -
Indoco announces the launch of Brinzolamide Ophthalmic Suspension 1% in the US market by Teva Pharmaceuticals
March 09, 2021
2020
-
Indoco wins major tenders in Germany for Allopurinol Tablets
December 08, 2020 -
Indoco launches FEVINDO 400 (Favipiravir 400mg Tablets)
September 26, 2020 -
Indoco receives USFDA approval for Apixaban Tablets
September 14, 2020 -
Indoco's Credit Rating upgraded by ICRA
September 10, 2020 -
Indoco receives USFDA approval for Olanzapine Tablets
August 06, 2020 -
Indoco receives USFDA approval for Succinylcholine Chloride Injection USP
May 26, 2020
2019
-
Indoco receives Approval for Febuxostat Tablets from USFDA
December 31, 2019 -
Indoco receives EU GMP from UK-MHRA for its Sterile facility in Goa (Plant II)
December 16, 2019 -
Indoco's CRO – AnaCipher receives EIR from USFDA
November 26, 2019 -
Indoco receives EIR for its manufacturing facilities in Goa (Plant II & III)
November 25, 2019 -
Approval of Glycopyrrolate ANDA filed from Indoco’s Goa Plant II
November 01, 2019 -
Indoco's Clinical Research Organisation receives zero 483s from USFDA
October 18, 2019 -
Indoco successfully concludes USFDA inspection at Goa Plant II
October 16, 2019 -
Indoco receives ANDA approval for Rasagiline Tablets
October 07, 2019 -
Indoco successfully completes UK-MHRA inspection at Goa Plant II
September 23, 2019 -
UK-MHRA reinstates full GMP status for Indoco's Goa Plant I
September 13, 2019 -
Indoco's CRO – ANACIPHER clears USFDA inspection with ZERO 483
August 12, 2019 -
USFDA clears Indoco's Goa Plant II & III
July 26, 2019 -
Indoco's Goa Plant I receives Warning Letter from USFDA
July 15, 2019 -
Indoco's New Solid Dosage facility at Baddi receives UKMHRA approval
May 08, 2019 -
USFDA retains the OAI status of Indoco's Goa Plant I
April 24, 2019 -
Indoco's Sterile Manufacturing Facility (Plant II) Clears USFDA
March 29, 2019 -
USFDA concludes audit at Indoco's Goa Plant I
January 28, 2019 -
Intimation of Schedule of Analyst/Institutional Investor Meetings from 23.01.2019 to 30.01.2019
January 22, 2019 -
Disclosure Under Regulation 30 of LODR Regulations 2015 USFDA Inspection - Updates
January 18, 2019 -
Disclosure Under Regulation 30 of LODR Regulations 2015 Media Report in Today's Economic Times
January 16, 2019
2018
-
Indoco commissions New API manufacturing facility at Patalganga
November 28, 2018 -
Indoco’s Goa Plant II & III clears USFDA inspection
November 22, 2018 -
Indoco's API mfg. facilities successfully clear USFDA inspection
May 18, 2018 Indoco's Goa Plant I gets statement of GMP non-compliance from UK-MHRA
April 25, 2018Indoco's Patalganga site gets Japanese Accreditation
April 04, 2018Indoco's Credit Rating by ICRA
April 04, 2018UK-MHRA inspection of Indoco's Goa Plant I
March 27, 2018Indoco's Goa plant III receives EU GMP certification
February 16, 2018
2017
2016
Indoco acquires Manufacturing plant in Baddi
September 21, 2016Indoco Remedies receives USFDA nod for its manufacturing facility (Goa Plant II)
May 25, 2016Indoco Remedies receives USFDA nod for solid dosages Plant I in Goa
March 21, 2016
2015
Indoco acquires Piramal's Clinical Research Division
April 01, 2015
2014
2012
Indoco Remedies Limited bags award for 'Innovation in Quality' at CPhI India Pharma Awards 2012
November 27, 2012Indoco CND, a new division for care in Cardiology and Diabetology
April 4, 2012Mr. Sundeep V. Bambolkar honoured for the second time at the ‘CFO 100 Awards’ 2012
March 29, 2012Third Generation takes over the Management reins at Indoco...
February 14, 2012Change of Company Secretary & Compliance Officer
February 8, 2012Indoco enters into a marketing and sales alliance with DSM, a € 9 billion Company
January 31, 2012